Jun 13, 2023 / 03:40PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Great. Thanks, everyone, for joining this morning. My name is Matt Sykes. I'm the life science tools and diagnostics analyst at Goldman Sachs. I have the pleasure of welcoming Max Krakowiak, the CFO of Revvity. Thank you very much, Max, for being here.
Maxwell Krakowiak - Revvity, Inc. - Senior VP & CFO
Absolutely.
Questions and Answers:
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research AnalystMaybe it would be great for you to start out kind of set the stage first to talk about the most recent results, trends you're seeing in your business. And also, there was a slight name change and everything. Maybe talk a little bit about that.
Maxwell Krakowiak - Revvity, Inc. - Senior VP & CFO
Yes, sure. So I think if we go back to the commentary we had on the first quarter call. Q1 came in, I would say, probably at the upper end of our expectations.